Leonabio, Inc. · NASDAQ:LONA
Perceptive Advisors LLC reported a 19.99% stake in Leonabio, Inc. (Schedule 13D/A)
Event Jan 16, 2026 · Filed Jan 16, 2026
Perceptive Advisors LLC reported a 19.99% stake in Leonabio, Inc., 1,859,322 shares, with active intent on Jan 16, 2026. Filed Jan 16, 2026 (Schedule 13D/A).
- Stake
- 19.99%
- Shares
- 1,859,322
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 19.99% | 1,859,322 |
| Joseph Edelman | 19.99% | 1,859,322 |
| Perceptive Life Sciences Master Fund, Ltd. | 16.40% | 1,529,566 |
| Perceptive Xontogeny Venture Fund II, LP | 3.50% | 329,756 |
Source
Related
- Leonabio, Inc.
- Perceptive Advisors LLC
- Leonabio, Inc. shareholders
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13G/A · Anders Hove · Jan 8, 2026